Navigation Links


dosing at Biology News

Duke to test bird flu vaccine dosing

A clinical trial to test different strengths of a vaccine designed to fight avian influenza will begin this month at Duke University Medical Center. The seven-month trial is spon...
dosing at Biology Products
dosing at Biology Technology
dosing at Medicine News

Hypertension lowered by Bedtime Dosing

Researchers in Japan have found that evening administration of the central alpha(2)-agonists guanabenz and clonidine effectively suppresses elevated blood pressure in the morning in hypertensive patients. The study was done on 133 patients with morning hypertension to receive once-daily evening administration of guanabenz or clonidine for four weeks. The blood pressure lowering effects of...

Researchers chides parents for overdosing their kids

Australian parents seem to be pretty good at assuming the role of a doctor but pretty bad at administering medicine doses. Infact, a survey at the Queensland University// of Technology has revealed that nearly half of all Australian parents give their children an incorrect dose of medication, almost always higher than it should be. Over medication can have very serious repercussions es...
dosing at Medicine Products

RxDrugs™: Drug Dosing Tool Special Mobile/Desktop Bundle

Description:Derived from the trusted, evidence-based AHFS Drug Information database, this continually updated tool provides dosing guidelines on thousands of commonly used brand and generic drugs and now includes nearly 400 integrated weight-based drug dosing calculators....
Company:Skyscape, Inc.
dosing at Medicine Technology

New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir

Minimal Weight Change Reported Unlike What Is Commonly Seen InInsulin Therapy CHICAGO, June 24, 2007 – Novo Nordisk today announcedresults of a new study that further demonstrated the safety andefficacy of insulin Levemir® (insulin detemir [rDNA origin]injection). Patients with Type 2 diabetes were able to adjusttheir own dosage of Levemir® and achieve improvements i...

Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target

New study demonstrates 75% of patients receiving highest doseachieves A1c with no associated hypoglycemia CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- According tofindings presented today at the 67th Scientific Sessions of theAmerican Diabetes Association (ADA) in Chicago, Illinois, theinvestigational treatment liraglutide, a once- daily dose of humanGLP-1 analog under development by...

New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir

Minimal Weight Change Reported Unlike What Is Commonly Seen InInsulin Therapy CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- Novo Nordisktoday announced results of a new study that further demonstratedthe safety and efficacy of insulin Levemir(R) (insulin detemir[rDNA origin] injection). Patients with type 2 diabetes were ableto adjust their own dosage of Levemir(R) and achieve improvem...

ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO

-- Genotypically Optimized Dosing Results in Improved Toleranceand Evidence of Anticancer Activity -- MELBOURNE, Australia, and MENLO PARK, California U.S.A. June 04,2007-ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) announcedtoday the presentation of data from its Quinamed (amonafidedihydrochloride) phase 1/2a dose-escalation study, designed toidentify a genotypically optimis...

ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO

MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--Jun4, 2007 - ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP)announced today the presentation of data from its Quinamed(R)(amonafide dihydrochloride) phase 1/2a dose-escalation study,designed to identify a genotypically optimised dose of Quinamed inheavily pre-treated patients with a variety of solid tumors. Thekey outcomes f...

More>>

Other TagsInvestInvestInvestInvestCreatineOliveOliveAndhraMiraculousAlcoholicsIbuprofen
(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2
(Date:7/25/2008)...08) New research published in the July issue of t...hows elevated plasma DNA is a reliable marker of r...s that plasma DNA levels rise before clinical evid...nts. , Esophageal cancer, one of the leading c...sed at a late stage. An accurate marker for detect...
(Date:7/24/2008)...l team led by Massachusetts General Hospital (MGH)...or genomic research and medicine a robust method ...articular DNA sequences for inactivation or repair...researchers describe an efficient, publicly availa...eases (ZFNs), which can be used to induce specific...
(Date:7/24/2008)...h a telescope promise to make it easier for people...ties requiring sharper distance vision. Schepens E...ntages of these innovative glasses over earlier de...e of Journal of Biomedical Optics , mailed in pr... design has several advantages," says the inventor...
(Date:7/24/2008)...uly 24, 2008 Adult stem cells originate in a diff... and with proper stimulation they can produce new ...jury, a study by UC Irvine scientists has shown. ,...s in the mammalian brain are the ependymal cells t...rd, rather than cells in the subventricular zone a...
Breaking Biology News(10 mins):Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds 2Consortium develops new method enabling routine targeted gene modification 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Adult stem cells activated in mammalian brain 2Adult stem cells activated in mammalian brain 3Elder Falls Bill Passes Congress Heads to President 16314 1Elder Falls Bill Passes Congress Heads to President 16314 2Elder Falls Bill Passes Congress Heads to President 16314 3Too many gene copies stimulate tumor cell growth 16312 1Center for Connected Health Presents Growing Evidence of the Benefits of Technology to Improve Patient Satisfaction and Empowerment 16309 1Center for Connected Health Presents Growing Evidence of the Benefits of Technology to Improve Patient Satisfaction and Empowerment 16309 2Center for Connected Health Presents Growing Evidence of the Benefits of Technology to Improve Patient Satisfaction and Empowerment 16309 3Center for Connected Health Presents Growing Evidence of the Benefits of Technology to Improve Patient Satisfaction and Empowerment 16309 4P 26G Declares a 14 25 Dividend Increase 16306 1
Other Contentsneuroscienceneuroscienceneuroscienceneuroscienceneuroscienceneurosciencecrassaneurotransmitterneurotransmitterneurotransmitterneurotransmitterneurotransmitterneurotransmitterneurotransmittermolecularmolecularmolecularmolecularmolecularmolecularmolecularmolecularmolecularmoleculartheorytheorytheorytheorytheorytheorytheoryneutralneutralneutralneutralneutralneutralneutralnondisjunctionendendendendendendendendendend